Prussian blue-modified ferritin nanoparticles for effective tumor chemo-photothermal combination therapy via enhancing reactive oxygen species production

Abstract

To realize the photothermal therapy ability of Prussian blue-modified ferritin nanoparticles (PB-Ft NPs) and its synergistic effect with chemotherapy, PB-Ft NPs were synthesized by a simple surface double decomposition reaction. Mean sizes of ferritin and PB-Ft NPs were 10.4 nm and 12.6 nm, respectively. The obtained PB-Ft NPs were verified to have both the photothermal conversion ability of Prussian blue and the morphology of ferritin. The in vitro and in vivo photothermal therapy results confirm PB-Ft NPs can successfully inhibit the growth of murine breast cancer cell line (4T1) without any obvious side effect. Moreover, taking use of the peroxidase-like activity of PB-Ft NPs, the photothermal therapy effect of PB-Ft NPs effectively improved the curative effect of gemcitabine (GEM) via enhancing reactive oxygen species production. The obtained PB-Ft NPs can be served as a useful and safe photothermal therapy agent in breast cancer. Moreover, PB-Ft NPs-assisted photothermal therapy can be applied as an adjunctive therapy with various established cancer treatments such as chemotherapy.

Keywords

Prussian blue photothermal therapy ferritin gemcitabine reactive oxygen species adjunctive therapy

Get full access to this article

View all access options for this article.

References

Roussakow

Where, when and why hyperthermia went wrong way?

Oncothermia J 2013; 7: 190–231.

Jiang

Luo

Men

et al . Red blood cell membrane-camouflaged melanin nanoparticles for enhanced photothermal therapy. Biomaterials 2017; 143: 29.

Qian

Cao

Long

YT.

Binary system for microRNA-targeted imaging in single cells and photothermal cancer therapy. Anal Chem 2016; 88: 8640–8647.

Wang

Liang

et al . Immunological responses triggered by photothermal therapy with carbon nanotubes in combination with Anti-CTLA-4 therapy to inhibit cancer metastasis. Adv Mater 2014; 26: 8154–8162.

Rashidi

Yao

et al . CuS nanoagents for photodynamic and photothermal therapies: phenomena and possible mechanisms. Photodiagnosis Photodyn Ther 2017; 19: 5.

Zhang

et al . A novel Met-IR-782 near-infrared probe for fluorescent imaging-guided photothermal therapy in breast cancer. Lasers Med Sci 2018; 33: 1601–1608.

Chen

Liang

Wang

et al . An albumin-based theranostic nano-agent for dual-modal imaging guided photothermal therapy to inhibit lymphatic metastasis of cancer post surgery. Biomaterials 2014; 35: 9355–9362.

Liu

Feng

et al . Prussian blue nanoparticles operate as a new generation of photothermal ablation agents for cancer therapy. Chem Commun (Camb) 2012; 48: 11567–11569.

Liu

et al . Magnetic Prussian blue nanoparticles for targeted photothermal therapy under magnetic resonance imaging guidance. Bioconjugate Chem 2014; 25: 1655.

10.

Cheng

Gong

Zhu

et al . PEGylated Prussian blue nanocubes as a theranostic agent for simultaneous cancer imaging and photothermal therapy. Biomaterials 2014; 35: 9844–9852.

11.

Yin

et al . Prussian blue as a highly sensitive and background-free resonant Raman reporter. Anal Chem 2017; 89: 1551–1557.

12.

Zhang

Yin

J-J

et al . Prussian blue nanoparticles as multienzyme mimetics and reactive oxygen species scavengers. J Am Chem Soc 2016; 138: 5860–5865.

13.

Maeda

Sawa

et al . Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000; 65: 271–284.

14.

Natfji

Ravishankar

Hmi

et al . Parameters affecting the enhanced permeability and retention effect: the need for patient selection. J Pharm Sci 2017; 106: 3179–3187.

15.

Cai

Cao

et al . Enhanced magnetic resonance imaging and staining of cancer cells using ferrimagnetic H-ferritin nanoparticles with increasing core size. Int J Nanomedicine 2015; 10: 2619.

16.

Han

Seaman

et al . Iron uptake mediated by binding of H-ferritin to the TIM-2 receptor in mouse cells. Plos One 2011; 6: e23800.

17.

Paragas

Ned

et al . Scara5 is a ferritin receptor mediating non-transferrin iron delivery. Dev Cell 2009; 16: 35–46.

18.

Yan

Zhang

Yang

et al . Therapeutic upregulation of Class A scavenger receptor member 5 inhibits tumor growth and metastasis. Cancer Sci 2012; 103: 1631.

19.

Turino

Ruggiero

Stefania

et al . Ferritin decorated PLGA/Paclitaxel loaded nanoparticles endowed with an enhanced toxicity towards MCF-7 breast tumour cells. Bioconjugate Chem 2017; 28: 1283–1290.

20.

Conti

Lanzardo

Ruiu

et al . L-Ferritin targets breast cancer stem cells and delivers therapeutic and imaging agents. Oncotarget 2016; 7: 66713–66727.

21.

Crich

Cadenazzi

Lanzardo

et al . Targeting ferritin receptors for the selective delivery of imaging and therapeutic agents to breast cancer cells. Nanoscale 2015; 7: 6527–6533.

22.

Goodall

Johnson

Wood

Validation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors: a multicentric 2004 national PHRC study. Int J Cancer 2012; 131: 426–437.

23.

Zhang

Chen

et al . Prussian blue modified ferritin as peroxidase mimetics and its applications in biological detection. J Nanosci Nanotech 2013; 13: 60–67.

24.

Zhang

et al . Prussian blue nanoparticles possess potential anti-inflammatory properties via scavenging reactive oxygen species. Inflamm Cell Signal 2016; 3: e1342.

25.

Han

Heo

et al . Metabolic characterization of imatinib-resistant BCR-ABL T315I chronic myeloid leukemia cells indicates down-regulation of glycolytic pathway and low ROS production. Leuk Lymphoma 2016; 57: 2180–2188.

26.

Sanchez-Sanchez

Gutierrez-Herrero

Lopez-Ruano

et al . NADPH oxidases as therapeutic targets in chronic myelogenous leukemia. Clin Cancer Res 2014; 20: 4014–4025.

27.

Zhang

Gong

Zhang

et al . Prussian blue modified iron oxide magnetic nanoparticles and their high peroxidase-like activity. J Mater Chem 2010; 20: 5110–5116.

28.

Stockwin

Han

BS.

Artemisinin dimer anticancer activity correlates with heme-catalyzed reactive oxygen species generation and endoplasmic reticulum stress induction. Int J Cancer 2010; 127: 1266–1275.

29.

Chen

Wang

Huang

et al . Prussian blue with intrinsic heme-like structure as peroxidase mimic. Nano Res 2018; 11: 4905–4913.

30.

Abdelwahed

Degobert

Stainmesse

et al . Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev 2006; 58: 1688–1713.

31.

Terashima

Uchida

Kosuge

et al . Human ferritin cages for imaging vascular macrophages. Biomaterials 2011; 32: 1430–1437.

32.

Kosuge

Sherlock

Kitagawa

et al . Near infrared imaging and photothermal ablation of vascular inflammation using single-walled carbon nanotubes. J Am Heart Assoc 2012; 1: e002568.

33.

Zhang

Goncalves

Mosser

DM.

The isolation and characterization of murine macrophages. Curr Protoc Immunol 2008; 83: 14.11.11–14.11.14.

34.

Weischenfeldt J and Porse B. Bone marrow-derived macrophages (BMM): isolation and applications. Cold Spring Harb Protoc 2008; 3: 1--6.

35.

Wang

Rykov

et al . Prussian blue/TiO2 nanocomposites as a heterogeneous photo-Fenton catalyst for degradation of organic pollutants in water. Catal Sci Technol 2015; 5: 504–514.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.27 MB